Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06333405
NA

Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC) - Clinical Study

Sponsor: Medical University of Warsaw

View on ClinicalTrials.gov

Summary

The aim of the study is to assess the safety of fecal microbiota transplantation (FMT) as a preventive method for the development of Necrotizing enterocolitis (NEC) in a group of premature infants. This is the first stage of a clinical trial testing the effectiveness of FMT in NEC, the aim of which is to examine the safety profile and analyze all side effects.

Official title: Evaluation of the Safety of Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC) in a Group of Newborns at Increased Risk for the Disease

Key Details

Gender

All

Age Range

24 Weeks - 36 Weeks

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-02-01

Completion Date

2027-10-30

Last Updated

2026-11-05

Healthy Volunteers

No

Interventions

DRUG

Fecal Microbiota Transplantation

Procedure: Fecal Microbiota Transplantation Fecal Microbiota as a suspension obtained from healthy unrelated donor (woman in 3rd trimester of pregnancy) introduced two times per treatment: * as a deep rectal infusion, via Foley's catheter inserted under ultrasound control, twice 6 hours apart, between 3 and 6 days after birth and/or up to 14 days * Other Names: MBiotix HBI

Locations (1)

Medical University of Warsaw, Pediatric Surgery Clinic

Warsaw, Mazovian Voivodeship, Poland